4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-016978
Options or other derivatives
- Chief Financial Officer acquired 147,937 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Jeanmonod Patrik Chief Financial Officer | 2023-03-03 | Grant or award · Employee Stock Option (Right to Buy) | +89,031 | 89,031 | D | ||
| Jeanmonod Patrik Chief Financial Officer | 2023-03-03 | Grant or award · Restricted Stock Units | +58,906 | 58,906 | D | ||
Loading xslF345X03/doc4.xml…